HSDT Solana Company logo

HSDT Solana Company

Healthcare
$2.29-2.97%ClosedMarket Cap: $133.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

0.89

P/S

13.94

EV/EBITDA

-3.39

DCF Value

$-11.54

FCF Yield

-13.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

94.2%

Operating Margin

-196.6%

Net Margin

-1427.1%

ROE

-155.3%

ROA

-68.2%

ROIC

-9.5%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$3.6M$-99.8M$
Q4 null$5.2M$325.6M$
FY null$6.0M$-40.9M$
Q3 null$697.0K$-352.8M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Fusion Summer Ltd10 percent owner
SellFri May 22
Fusion Summer Ltd10 percent owner
SellFri May 22
Fusion Summer Ltd10 percent owner
SellFri May 22
Chee Choon Weedirector, 10 percent owner, officer: Executive Chairman
SellWed May 13
Chee Choon Weedirector, 10 percent owner, officer: Executive Chairman
SellWed May 13

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.07

Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Peers